Aldeyra Therapeutics Inc (ALDX) Implied Volatility Current

Tracking ALDX implied volatility helps you identify when options premiums on Aldeyra Therapeutics Inc are historically cheap or expensive, and where the best trades are hiding. Aldeyra Therapeutics Inc implied volatility reflects the market's expectation of future price movement: when ALDX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Aldeyra Therapeutics Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ALDX, tracking metrics like ALDX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ALDX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma.

The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ALDX implied volatility sits today versus where it has been. Our scanner ranks Aldeyra Therapeutics Inc implied volatility against its historical range, surfaces extremes in ALDX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Aldeyra Therapeutics Inc IV is rich or cheap — measure it, then act on it.